IDV vehicle
36E79726D0032
NEW AWARD FOR ROPINIROLE HCL TABLETS WITH SOLCO HEALTHCARE US, LLC. PERIOD OF PERFORMANCE IS 9/28/2026 - 9/27/2027
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $8.6M |
| Start date | Sep 28, 2026 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jun 17, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 17, 2026 | 0 | $0 | NEW AWARD FOR ROPINIROLE HCL TABLETS WITH SOLCO HEALTHCARE US, LLC. PERIOD OF PERFORMANCE IS 9/28/2026 - 9/27/2027 |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.